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Original Article
Abstract
Purpose: The present work pursues perfection of highly efficient anticancer, principally new methodology and technology. It
deals with the comparative study of anticancer activity of controlled local hyperthermia in animals and development of optimal
regimes and schemes. Furthermore, it also presents the work on new clinical device of high anticancer effect. Methods: Authors
used controlled local hyperthermia for this study. In our experiments, we used 3 to 3.5 months-old non-pedigree (nonlinear)
white mice (mass: 18-30 gram). After mice selection for the experiments, animals were placed in vivarium, in quarantine regime
for 10 to 4 days. Individual protocols were drawn for each animal. Similar feeding and handling regimes were created for all
animals. Transplantable malignant cancer strain, Erlich adenocarcinoma, was used. Results: Experiments on animals were suc-
cessful. There are positive conclusions of pathological-anatomy laboratory “PathGeo”: Form # IV -200- 6A, for the examination
3119-12 and # 15/02 and macro-morphological and micro-morphological description of the study # 15272-13. On the basis of
results of morphological study, it was proved that liver and lungs (the main target bodies) were intact, and secondary cancer
injuries were not fixed. After three sessions of hyperthermia treatment, the decrease in sizes of cancer formations and necrosis
diseased sections were visualized, while massive necrosis was observed after seven sessions. In all cases, necrosis and ulceration
diseased places were observed, which refers to transition of cancer into phase of healing. After eight-ten sessions, necrosis of
cancer and ulceration were observed, which refers to irreversibility of the process and efficiency of the applied method of hy-
perthermia. Conclusion: Anticancer effect of hyperthermia conditioned by temperature fields was proved, which was expressed
in inhibition of cancer growth, resorption and increase of life length of experimental animals. The method of treatment was
selected with maximum anticancer effect free of side effects and was offered as a new, perspective alternative or additional
for treatment of malignant cancers.
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Introduction
According to the data of the World Health Organization
(WHO), morbidity and lethality index that is conditioned by
melignancies has been growing permanently all over the
world. Today, the leading role in treatment of oncology pa-
tients is attributed to surgical methods, chemo- and radiation
therapy. Immuno- and hormone therapies are considered as
addition to the main methods of treatment.1-14
Although in frequent cases, irrespective of skillfully per-
formed surgeries, lethal outcomes have been reported.
Alongside with poly-organic insufficiency, this is caused by
suppression of immune system induced by chemo-radioth-
erapy, myelodepression, leucopenia, cardio, nefro-, hepato-
and neuro-toxicity, inter-current microbial complications
and others. These conditions necessitate the search of new
approaches of treatment of malignancies focused on amplifi-
cation of anti-cancer strategies.15-24
In this study, anti-cancer effect of hyperthermia has been
investigated. Hyperthermia is a method, which implies ci-
tostatic impact on cancer cells by increase of temperature in
cell - by the mechanisms of thermal dissipation conditioned
by hyperthermic field. The working team consisted of cera-
mists, oncologists, physicists, immunologists, and specialists
of electronics sphere. On the basis of experimental materials
used in this study, the impact of anti-cancer mono-
-therapeutic treatment and its adventitial effect in poly-
chemo-therapeutic treatment of cancers have been presented
for the first time in Georgia. With this in view rational hy-
perthermia schemes were developed.25-31
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Authors have created a device called “Lezi”. For the im-
provement of “Lezi’s” efficiency, a clinical device “Lezi 1” was
constructed in order to shift treatment to a clinic for treat-
ment of patients at the starting stage after an agreement with
the Oncology Center. It should be emphasized that experi-
ments on animals were successful. There is a positive conclu-
sion of laboratory of Morbid Anatomy “PathGeo”, Form #
IV-200 -6/A about macro-morphologic and micro-mor-
phologic description.
The significance of the work is that by hyperthermic
head/nose of a device created by us in laboratory conditions
(Figure 1), temperature field is transported to animal skin and
underneath it. The nose can be placed on the cancer site for a
definite time, which was determined empirically, based on
the reaction of an animal and disease to the treatment.
FIG. 1: (a) Laboratory device “Lezi” (left), cage with mice (right); (b)
Clinical therapeutic device “Lezi 1” created at the Bionanoceramic
and Nanocomposite Materials Science Center of Georgian Technical
University.
In this research project, authors expect to provide:
1. Confirmation of anti-cancer effect of hyperthermia
conditioned by temperature fields, to be expressed
in inhibition of cancer growth, possible resorption,
and increase of life length of experimental animal.
2. Selection of optimal anti-cancer method with
minimal side effects (or without these effects) and
its offering as a new, perspective alternative or ad-
ditional therapeutic means against malignant tu-
mors/cancers.
Methods and Materials
Hyperthermia is a Greek word and it means warming and
overheating. It is one of the declared methods for cancer
therapy in USA, Europe, and Japan with no con-
tra-indications. Two forms of hyperthermia are used against
oncology diseases: hyperthermia of the whole body and/or
local hyperthermia. In this case, internal temperature of the
whole body or any concrete body is increased from 42oC to
44oC, resulting in destruction of tumor cells. This does not
mean simple warming of external part of a body; it implies
heating of the whole body or only cancer formation sections,
by means of micro- or radio- waves, as well as by exposure to
infrared (IR) radiation.
In our experiments, we used 3 to 3.5 months-old
non-pedigree (non-linear) white mice (18-30 g mass). After
their selection for experiments, within 10-14 days animals
were placed in vivarium, in quarantine regime. Individual
protocols were drawn for each separate animal. Animals were
kept at similar nutrition and handling conditions. Experi-
ments were carried out by the use of Erlich adenocarcinoma
(EAT, ascitic version) and S-45 (sarcoma fusocellulare) cancer
strains. Inoculation of Erlich adenocarcinoma was performed
(by oncologists) in mice, intra-peritoneally, that of S-45-
subcutaneously, in subscapular zone. Injection of the studied
preparation was made peri- and intra-tumorally.
Experiments were performed by the methods widely used in
experimental oncology. Anti-cancer effect of the studied
preparation was considered according to frequency of cancer
formation, growth inhibition, animal weight change, ascitic
liquid reduction, and changes in indices of animal life pro-
longation.
Mono-therapeutic anti-cancer effect of hyperthermia
We have been studying anti-cancer effect of hyperthermia
since 2007. On the first day of the experiment (June 06, 2013),
subcutaneous inoculation of EAT cancer strain was per-
formed in the vivarium of State Medical University in Tbilisi,
Georgia. All animals of experimental group developed cancer.
Animals were shifted from the vivarium of the State Medical
University to the vivarium of Bionanoceramic and Nano-
composite Science Center of Georgian Technical University
for the commencement of their treatment.
On July 04, 2013, we measured animal cancers (see Table 2),
and on the very day we carried out the first session of hy-
perthermia. Nose of the hyperthermia device, on the top of
which temperature reached 42oC to 44oC, was placed on
cancer formation. Length of hyperthermia manipulation
equaled to 30 minutes.
Experiments proved that in #1, 2, and 3 animals cancer
growth was inhibited (suspended). Necrosis was already de-
tected by the fourth session. In the fourth session, as a result
of treatment by hyperthermia, we observed the so-called
“intra tumor necrosis”, that is, necrosis of cancer cells was
developed. During treatment of skin and subcutaneous can-
cers/tumors by the methods of hyperthermia (first group)
experiments were carried out on 12 groups, but we are of-
fering here the results of the last two groups, as common
characteristic ones. After every two or three sessions cancers
of animals were photographed. Pictures are given in Figures
2-6.
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TABLE 1: Results of experiments on animals
# 1 animal
cancer sizes L, B, H= 12 × 10
× 8 mm
# 2 animal
cancer sizes L, B, H= 12 × 10
× 8 mm
# 3 animal
cancer sizes L, B, H= 14 × 14
× 10 mm
Length of the I session)
(July 04, 2013)
30 min
(Inhibition of cancer growth
is observed)
30 min
(Inhibition of cancer growth
is observed)
30 min
(Inhibition of cancer growth
is observed)
Length of the II session
(July 06, 2013)
30 min 30 min 30 min













12 × 12 × 8 mm)
30 min
(Ulceration around diseased
site is observed; cancer sizes




10 × 8 × 8 mm)











Length of the VI session
(July 14, 2013)
35 min 35 min 25 min
Length of the VII session
(July 16, 2013)
35 min 35 min (Was not subjected because
of acute ulceration)




zone, there is no cancer; sizes




zone, there is no cancer;
sizes of treated section
8 × 5 × 3 mm)
30 min
(Ulceration around cancer
zone, there is no cancer;
sizes of treated section
3 × 3 × 3 mm)
Abbreviations: L = length; B = breadth; H = height
FIG. 2: After the first session (July 04, 2013) [#1 has two cancer formations]
FIG. 3: After the third session (July 08, 2013) [#1-has two cancer formations]
FIG. 4: After the fifth session (July 12, 2013) [#1 has two cancer formations]
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FIG. 5: After the eighth session (July 18, 2013) [#1 has two cancer formations]
FIG. 6: Treated animals by the end of December 2013 (six months after termination of treatment).
Results and Discussion
After the very first session of the experiment, suspension of
tumor growth was observed in all three animals of the first
group, while after the third session, all three animals re-
vealed necrosis of cancer cells. Necrosis that was developed
in #2 animal of the first group considered in the paper was
apparent at the fourth session. The #2 animal revealed
ulceration around the diseased section after the fourth
session. In the process of experiments mice positively
responded to the process of therapy.
After the fifth session, all three animals of the first group,
which were considered in the paper, revealed ulceration
around diseased section. We received #1 animal with two
cancer formations. One was treated and the other was left
without treatment just for comparison. In the process of
therapy, necrosis of the treated cancer was clearly detecta-
ble, while the other tumor continued to grow. After the
eighth session, complete necrosis of the treated cancer for-
mation and ulceration around cancer sections were observed,
which refers to transition of a disease to the phase of healing.
The #1 animal, which had a tumor that was left untreated,
died in three weeks after the end of treatment. Almost the
same results are presented for animals of the second group.
Animals were under permanent post-treatment observation.
Six months after the completion of the treatment cancer was
cured.
Anticancer effect, in the case of the first group and the sec-
group, was assessed according to the decrease of cancer mass,
cancer tissue necrosis, and complete disappearance of cancer.
Likewise, cancer tissue was studied in dynamics by morpho-
logical method, by correlation of cancer necrosis and cancer
mass and necrotic sections. On the basis of the results of
morphological study, it was proved that liver and lungs (the
main target bodies) were intact, and secondary cancer
were not fixed.After three sessions of hyperthermia treat-
ment, in both groups given in the paper, decrease in sizes of
cancer formations and necrosis of diseased sections were
visualized, while massive necrosis was observed after seven
sessions. In all cases, necrosis and ulceration of diseased
were observed, which refers to transition of cancer into
of healing. After eight-ten sessions, again necrosis of cancer
and ulceration were observed, which refers to irreversibility
of the process and efficiency of the applied method of hy-
perthermia.
This phenomenon was characteristic for mice of twelve
groups, which were subjected to controlled local hyperther-
mia within these years. In all, experiments were performed
on 55 to 60 mice, and inhibition of cancer growth and in-
tra-tumor necrosis were conditioned by the effect of con-
trolled local hyperthermia used by us. Visual observations
were confirmed by the results obtained for all animals: by
measurements and photos made after three, seven, and ten
sessions.
FIG. 7: After the first session (December 10, 2013)
FIG. 8: After the third session (December 14, 2013)
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FIG. 9: After the sixth session (December 22, 2013)
FIG. 10: After the eighth session (December 26, 2013)
TABLE 2: Treatment of skin and subcutaneous cancer diseases by





8 × 6 × 5 mm 10 × 7 × 5 mm
Duration of the I session
(December 10, 2013)
25 min 25 min
Duration of the II session
(December 12, 2013)
30 min 30 min
Duration of the III session
(December 14, 2013)
30 min 30 min
Sizes after  the IV session
(December 16, 2013)
9 × 7 × 5 mm 14 × 11 × 8 mm
Duration of the IV session
(December 16, 2013)
30 min 30 min
Duration of the V session
(December 18, 2013)
30 min 30 min
Duration of the VI session
(December 20, 2013)
35 min 35 min
Sizes after the VI session
(December 22, 2013)
Necrosis is observed
7 × 6 × 5 mm 16 × 14 × 9 mm
Duration of the VII session
(December 22, 2013)
30 min
Duration of the VIII session
(December 24, 2013)
30 min




After the VII session, we
stopped sessions with #2 mouse,
because lymph started leaking
from cancer. It was subjected to
higher than needed tempera-
ture: 44-460 C
Three or four sessions were left to the end of treatment, but
on the advice of oncologists both animals were butchered,
and liver and lung analyses were performed at the Laborato-
of Morbid-Anatomy “PathGeo”, to see the possibility of me-
tastasis spreading in those bodies. Analysis with correspond-
ing figures and descriptions are provided below.
FIG. 11: Liver, animal #1; Black arrow shows blood tube, with the
presence of erythrocytes in it; Blue arrow shows hepatocytes around
blood tube (liver cell); [Cancer cells are not fixed in preparation]
FIG. 12: Liver, animal #1; Black arrow shows lung alveolus; Blue
arrow shows the first order alveolocytes; Red arrow shows erythro-
cyte; [Cancer cells are not observed in this preparation. On the basis
of results of morphological study no cancer cells were found in liver
and lungs]
FIG. 13: Cancer, animal #1; Blue circle shows necrotic masses; Red
circle shows cariorexis (process of cell nucleus degradation); [Cancer
cells are fixed, with acute polymorphism which is inherent to Erlich
adenocarcinoma]
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FIG. 14: Cancer, animal #1; [This figure shows necrosis]
FIG. 15: Liver, animal #2; Blue arrow refers to hepatocytes around
blood tube; [Cancer cells are not fixed]
FIG. 16: Liver, animal #2; Red circle shows lung alveoli, bedded with
alveolocytes; Blue arrow shows fibrotic tissue; [according to the
results of morphological studies, there are no cancer metastasis in
liver and lung]
FIG. 17: Cancer, animal #2; Blue arrow shows subcutaneous fatty
tissue; Red arrow shows longitudinal muscle tissue of platisma; Black
arrow shows nerve fiber; Red circle shows cancer cells proliferate;
Black oval shows necrosis center
FIG. 18: Cancer, animal #2; Black circle shows necrosis center; Blue
circle shows proliferates of traces of cancer cells
Conclusion
After measuring temperature by thermometer, it was proved
that in tissues surrounding cancer temperature decreases and
reached that of a body. The highest temperature was fixed in
cancer projection area on skin and it equalled to 44oC.
Within 10-12 mm distance from cancer tissue, we fixed
normal body temperature. Anti-cancer effect was assessed by
decrease of cancer mass, necrosis of cancer tissue, and abso-
lute disappearance of tumour. We have also studied the ef-
fect in dynamics by morphological study method of cancer
tissue, cancer necrosis as well as correlation of cancer mass
and necrotic sections. On the basis of results of morphologi-
cal studies, it was proved that liver and lungs (the main tar-
get bodies) are intact, and secondary cancer damages are not
fixed.
Furthermore, after three sessions of hyperthermia treatment,
the decrease in sizes of cancer formations and necrosis of
diseased sites were observed in all animals, whereas massive
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necrosis was observed after seven sessions. In all cases, ne-
crosis and ulceration were observed, which refers to irre-
versibility of the process and efficiency of the applied meth-
od of hyperthermia. Results of histo-pathologic studies
proved vividly expressed anti-cancer effect of local hyper-
thermia. Figures offer cancer cells of polymorphous nucleus
and vast zones of necrosis - which is the result of impact of
high temperature on cancer tissue. It should be noted that
70-90% of cancer mass is necrotic, and central necrosis was
observed. Metastatic injuries were not fixed in the bodies.
On the basis of the available material, we can state that at
lysis of cancer mass that is conditioned by local hyperther-
mia, and the formation of metastasis does not develop in the
studied bodies.
Finally, our group has constructed a new clinical device
“Lezi 1” (Figure 1 (b)), which will be utilized at the Clinical
Oncology Institute, in Tbilisi. Five volunteers (patients) will
be subjected to treatment of surface cancer diseases by the
method of hyperthermia developed by our research group.
In the near future, we plan to create a new device for treat-
ment of proctologic cancer diseases.
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